Topics

Biogen Inc.: Landmark NURTURE Study of Infants with Spinal Muscular Atrophy (SMA) Treated Pre-Symptomatically with SPINRAZA (nusinersen) Published in Neuromuscular Disorders

07:41 EDT 2 Oct 2019 | FinanzNachrichten

Treatment with SPINRAZA resulted in survival of 100 percent of infants, with none requiring permanent ventilationMotor milestones achieved included 100 percent of participants sitting without suppo...

Original Article: Biogen Inc.: Landmark NURTURE Study of Infants with Spinal Muscular Atrophy (SMA) Treated Pre-Symptomatically with SPINRAZA (nusinersen) Published in Neuromuscular Disorders

NEXT ARTICLE

More From BioPortfolio on "Biogen Inc.: Landmark NURTURE Study of Infants with Spinal Muscular Atrophy (SMA) Treated Pre-Symptomatically with SPINRAZA (nusinersen) Published in Neuromuscular Disorders"

Quick Search